Skip to main content
Premium Trial:

Request an Annual Quote

Invitrogen, Phoenix S&T, Bruker Daltonics, Isis Pharmaceuticals

Premium
Invitrogen lauched this week the iBlot Dry Blotting system and the iPrep purification instrument.
 
The iBlot system transfers proteins from polyacrylamide gels to nitrocellulose membranes in preparation for downstream analysis. The iPrep instrument automates nucleic acid purification using Invitrogen’s ChargeSwitch technology.
 

 
Phoenix S&T this week launched its SureSpray technology for mass spectrometry analysis of proteins and metabolites. In a statement, Phoenix said SureSpray’s orifice is larger than that of nanospray ionization technology. That and its inert plastic surfaces reduce the clogging and variation in signal intensity found with the nanospray ionization method, the company said.
 
The SureSpray is available for shipment and is available in chip format and HPLC columns.
 

 
Bruker Daltonics and Isis Pharmaceuticals this week launched the Ibis T5000 biosensor system in Europe. The system is used for the identification and characterization of micro-organisms and uses Bruker’s micrOTOF ESI TOF mass spectrometer.
 
In July the companies announced an agreement whereby Bruker would be the exclusive worldwide manufacturer of the T5000 system. The agreement gives Bruker exclusive rights to sell T5000 in Europe.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.